Black Bird Biotech, Inc. (BBBT)

0.0002 +0.0001 (+50.00%) At close: 01:49PM EDT

Black Bird Biotech, Inc.

11961 Hilltop Road
Suite 22
Argyle, TX 76226
United States
833 223 4204
https://www.blackbirdbiotech.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Fabian G. Deneault	Chairman of the Board & President	90k	N/A	1967
Mr. William E. Sluss	CFO, VP of Finance & Director	60k	N/A	1955
Mr. Eric Newlan	VP, Secretary & Director	80k	N/A	1962
Mr. Nelson Grist	Chief Executive Officer	N/A	N/A	N/A
Mr. William J. LoBell	Executive Vice President of Sales & Development	N/A	N/A	1948

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Argyle, Texas.

Corporate Governance

Black Bird Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.